Fortress Companies

Home » Fortress companies » avenue therapeutics

Avenue Therapeutics, Inc.

Avenue Therapeutics, Inc. (“Avenue”), a Fortress Biotech Company, is a specialty pharmaceutical company focused on the development and commercialization of intravenous (IV) tramadol for the management of moderate to moderately severe postoperative pain. IV tramadol, a Schedule IV opioid, may provide less addiction potential than traditionally prescribed therapies, and fill a gap in the acute pain market between IV acetaminophen/NSAIDS and IV conventional narcotics. Avenue is currently evaluating IV tramadol in a pivotal Phase 3 trial for the management of postoperative pain following bunionectomy surgery.  Avenue is headquartered in New York City.  

For more information, please visit www.avenuetx.com.